Table 2 Cutaneous reactions associated with dipeptidyl peptidase-4 inhibitors reported in case reports. (bullous pemphigoid not included)

1.

Krupa A. Sunil,2022 [16]

Exanthematous drug eruption

Teneligliptin

63/M

Hypertension, Benign prostatic hypertrophy

Metformin, Glimepiride

A few hours

7 d

2.

Dana Al Masri,2021 [17]

FDE

Vildagliptin

58 /F

–

Metformin, Gliclazide, Empagliflozin

2 w

2 w

3.

Jessica Kaushal,2020 [18]

FDE

Vildagliptin

58 /M

–

Metformin

N/A

2 d

4.

Ankur Guliani,2019 [19]

Eczematoid dermatitis

Vildagliptin

54 /F

–

Metformin

Voglibose

2 m

1 m

5.

Miao Zheng,2018 [20]

Exanthematous drug eruption

Linagliptin

41/F

Behcet disease

Prednisolone, Infliximab

2 m

1 m

6.

Elena Succurro,2017

[21]

Loss of eyebrows and eyelashes

Sitagliptin

69/M

–

Metformin

4 m

3 m

7.

Mrinal Gupta,2015 [22]

FDE

Sitagliptin

46/F

–

Metformin

1 w

5 d

8.

C Sin,2012 [23]

DRESS

Sitagliptin

66/F

Obesity, Hypertension

Metformin, insulin, Telmisartan

3 w

2 w

9.

Kaori Nakatani,2012 [24]

Exanthematous drug eruption

Sitagliptin

66/M

–

Metformin

6 m

2 m

10.

Sherea M Stricklin,2012 [25]

Photosensitivity reaction

Sitagliptin

65/ M

–

–

2 w

2 y

11.

Keiko TANAKA,2011 [26]

Exanthematous drug eruption

Sitagliptin

62/F

HTN

Trichlormethiazide, Telmisartan, Metformin, Glimepiride

2 w

1 w